CHICAGO -- Allscripts Healthcare Solutions, Inc. (Nasdaq:MDRX) announced today that it intends to offer 7.3 million shares of common stock, pursuant to a preliminary prospectus supplement to be filed with the Securities and Exchange Commission under Allscripts' shelf registration statement.
The Company intends to use all of the net proceeds from the offering to finance the proposed acquisition of A4 Health Systems, Inc. If the acquisition is not consummated, the proceeds will be used for general corporate purposes.
The offering will be led by Lehman Brothers and UBS Investment Bank as joint book-running managers. Jefferies Broadview, William Blair & Company, Piper Jaffray and Goldman, Sachs & Co. will be co-managers for the offering. Allscripts will grant the underwriters an option to purchase up to an additional approximately 1.1 million shares from Allscripts if the underwriters sell more than 7.3 million shares of common stock in the offering.
A copy of the preliminary prospectus supplement and prospectus relating to the offering may be obtained from Lehman Brothers, Prospectus Department, c/o ADP Financial Services, Integrated Distribution Services, 1155 Long Island Avenue, Edgewood, New York, NY 11717 and UBS Investment Bank, 299 Park Avenue, New York, NY 10071. These documents are being filed with the Securities and Exchange Commission and will be available over the Internet at the SEC's web site at http://www.sec.gov.
Allscripts is a provider of clinical software, connectivity and information solutions that physicians use to improve healthcare. Allscripts' Clinical Solutions Group's clinical software applications include Electronic Health Record, e-prescribing and document imaging solutions. Additionally, Allscripts provides clinical product education and connectivity solutions for physicians and patients through its Physicians Interactive(TM) Group and medical fulfillment services through its Medication Solutions Group.
|